<code id='759D817843'></code><style id='759D817843'></style>
    • <acronym id='759D817843'></acronym>
      <center id='759D817843'><center id='759D817843'><tfoot id='759D817843'></tfoot></center><abbr id='759D817843'><dir id='759D817843'><tfoot id='759D817843'></tfoot><noframes id='759D817843'>

    • <optgroup id='759D817843'><strike id='759D817843'><sup id='759D817843'></sup></strike><code id='759D817843'></code></optgroup>
        1. <b id='759D817843'><label id='759D817843'><select id='759D817843'><dt id='759D817843'><span id='759D817843'></span></dt></select></label></b><u id='759D817843'></u>
          <i id='759D817843'><strike id='759D817843'><tt id='759D817843'><pre id='759D817843'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:6
          glum Benjamin — health insurance coverage from STAT
          Adobe

          Three biotech VC veterans, including one of the co-founders of radiopharma success story RayzeBio, are launching a new investment fund called Scion Life Sciences.

          Scion was started by former Apple Tree Partners colleagues Sam Hall and Aaron Kantoff, along with Tadd Wessel, managing partner of the health care private equity firm Petrichor. They raised $310 million for its first fund, blowing past their original $250 million target.

          advertisement

          They’re planning on taking a different tack with biotech venture capital. For starters, Scion plans to work on a significantly longer timeframe. Most firms in existence today write checks, help investments grow, and find a way to recoup their money in a 10-year timeframe. Scion is doubling that, setting a 20-year plan for its first fund.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Key House panel plots a new health care package
          Key House panel plots a new health care package

          CommitteechairmanRep.JasonSmith(R-Mo.)speakswithrankingmemberRep.RichardNeal(D-Mass.).DrewAngerer/Ge

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          In early work, researchers turn to CRISPR to treat Alzheimer's

          AdobeWhenthegenome-editingtoolCRISPRisthoughtofasapotentialmedicine,thetargetsthatfirstcometomindare